A proposed new method for assessing the pathological response to chemotherapy in resected colorectal liver metastases. - Wikidata - awgldk - TriplyDB

A proposed new method for assessing the pathological response to chemotherapy in resected colorectal liver metastases.

A proposed new method for assessing the pathological response to chemotherapy in resected colorectal liver metastases.

http://www.wikidata.org/entity/Q33994298

about

Evidence of intermetastatic heterogeneity for pathological response and genetic mutations within colorectal liver metastases following preoperative chemotherapy.Patient selection for the surgical treatment of resectable colorectal liver metastases.Tumor histopathology predicts outcomes after resection of colorectal cancer liver metastases treated with and without pre-operative chemotherapy.Impact of homogeneous pathologic response to preoperative chemotherapy in patients with multiple colorectal liver metastases.Pathological factors and prognosis of resected liver metastases of colorectal carcinoma: implications and proposal for a pathological reporting protocol.Long-term survival and cure model following liver resection for breast cancer metastases.Rare genetic heterogeneity within single tumor discovered for the first time in colorectal liver metastases after liver resection.

P2860

Q37225348-B491679A-76DC-4860-AF86-66A77F7B14CA Q38990110-ACA2B4FB-0863-4275-86C7-7DF5821662E6 Q45032127-ED6E98F9-D3FF-45C7-A1E3-D41A9E49A274 Q47098653-C9BFF37F-B735-4187-976B-0BC128468A93 Q48146966-3A3DBD72-D059-4F76-94AA-7E02C2FE083C Q49721558-5F7578C8-9D0F-478A-9043-F07CB138E020 Q55002562-73F0E5C0-4E3A-448E-8C44-13529E219F1F

P2860

A proposed new method for assessing the pathological response to chemotherapy in resected colorectal liver metastases.

http://www.wikidata.org/entity/Q33994298

description

2014 nî lūn-bûn

@nan

2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

A proposed new method for asse ...... d colorectal liver metastases.

@ast

A proposed new method for asse ...... d colorectal liver metastases.

@en

type

label

A proposed new method for asse ...... d colorectal liver metastases.

@ast

A proposed new method for asse ...... d colorectal liver metastases.

@en

prefLabel

A proposed new method for asse ...... d colorectal liver metastases.

@ast

A proposed new method for asse ...... d colorectal liver metastases.

@en

P1433

Q33994298-393141DE-921B-4E1F-AFC2-F81CEC99476B

P1476

Q33994298-A6F4CA3A-0346-4229-9BA3-1D46051378CD

P2093

Q33994298-00EDCF17-4113-459E-B440-1825C92FCF76

Q33994298-0E301CE6-F40E-4363-B7F3-9D1421992CAE

Q33994298-1B30A926-8DFF-4271-8014-D58A27E288CA

Q33994298-3DDDAE86-1667-4717-9F2D-A158556BA861

Q33994298-42AA5D98-8AE5-4327-986B-2CA91A54808E

Q33994298-570E62A2-8736-4F28-BA97-BB68FE167285

Q33994298-5A82B3D3-AEA8-4367-A890-0B28B62D38B1

Q33994298-BDB64924-D635-42C6-A317-B8423D88B633

Q33994298-D3FE5F49-1FAD-478A-93A6-887E74D08AA0

Q33994298-E37DB082-9BA5-4A2A-A2FF-A02A614D9BF3

P2860

Q33994298-01964D09-1153-41D5-A1F0-17367E5E0735

Q33994298-31A11180-10CB-437B-BDE8-10A62352E5A2

Q33994298-379213CD-4818-4A46-A899-71B46FD1F75B

Q33994298-55E31B60-0F1F-4DE6-9E83-233071FDFA80

Q33994298-5C3AE455-EFA3-48ED-8D7E-C363947F7A00

Q33994298-6608755B-9079-45C0-8C57-3F332A94D4A7

Q33994298-705A4E99-07BE-47B6-A9E7-09EDECD9648C

Q33994298-7297CB1E-8607-4E61-AF80-F07C13032770

Q33994298-79A30C59-42EE-468B-BFE1-2D9648B17E26

Q33994298-7D6F510B-3930-40B6-B7EA-A0AF64EB2C92

P2888

Q33994298-1094FC19-731F-470D-9F01-FEAE39A1A597

P304

Q33994298-BA05CBA9-7F60-420E-8A84-451101B16CE4

P31

Q33994298-23CB379D-B587-4E1A-90FA-33ACB631120A

P356

Q33994298-7AB8432A-0759-4479-914B-B29DAEDAB152

P407

Q33994298-62E5C79D-B30E-4055-9AD2-F8F4A2DB6EE6

P433

Q33994298-86F76F2E-5490-4EBD-8AC0-3B0F6D8733CE

P478

Q33994298-F8E3728A-097E-40C8-8755-6E4557508360

P577

Q33994298-5F39AA7A-9DEE-43A1-AEF5-68F0B34F4ED2

P5875

Q33994298-1D1EA10A-F524-424B-8452-0F1D169436B6

P6179

Q33994298-1D6C24FB-8030-43F4-AD4E-CB1EB5C0B4D2

P698

Q33994298-58FC53E5-4F45-4DE7-90D6-0026BEC68184

P921

Q33994298-0A66B2B8-AAB3-4AF7-8EF8-8AF3B427EB55

P932

Q33994298-DE60667D-8DDD-45B6-A6DB-4504700EF1FE

P356

P1433

British Journal of Cancer

P1476

A proposed new method for asse ...... d colorectal liver metastases.

@en

P2093

A Lemoine

http://www.w3.org/2001/XMLSchema#string

A Ruiz

http://www.w3.org/2001/XMLSchema#string

A S Cunha

http://www.w3.org/2001/XMLSchema#string

B Paule

http://www.w3.org/2001/XMLSchema#string

D Cherqui

http://www.w3.org/2001/XMLSchema#string

E Vibert

http://www.w3.org/2001/XMLSchema#string

M Sebagh

http://www.w3.org/2001/XMLSchema#string

M-A Allard

http://www.w3.org/2001/XMLSchema#string

R Adam

http://www.w3.org/2001/XMLSchema#string

R Araujo

http://www.w3.org/2001/XMLSchema#string

P2860

Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial

Histopathologic evaluation of liver metastases from colorectal cancer in patients treated with FOLFOXIRI plus bevacizumab.

Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases.

Multicenter validation study of pathologic response and tumor thickness at the tumor-normal liver interface as independent predictors of disease-free survival after preoperative chemotherapy and surgery for colorectal liver metastases.

Tumor thickness at the tumor-normal interface: a novel pathologic indicator of chemotherapy response in hepatic colorectal metastases.

Pathologic response to bevacizumab-containing chemotherapy in patients with colorectal liver metastases and its correlation with survival.

Liver resection for colorectal metastases after chemotherapy: impact of chemotherapy-related liver injuries, pathological tumor response, and micrometastases on long-term survival.

Preoperative prognostic score for predicting survival after hepatic resection for colorectal liver metastases.

R1 resection by necessity for colorectal liver metastases: is it still a contraindication to surgery?

Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin-based chemotherapy for colorectal liver metastases.

P2888

P304

470-476

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.2014.299

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

111

http://www.w3.org/2001/XMLSchema#string

P577

2014-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264393730

http://www.w3.org/2001/XMLSchema#string

P6179

1041418572

http://www.w3.org/2001/XMLSchema#string

P698

25072303

http://www.w3.org/2001/XMLSchema#string

P921

P932

4119974

http://www.w3.org/2001/XMLSchema#string